Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.

Yuan C, Wang C, Liu X, Kong B.

Mol Biol Rep. 2013 Oct;40(10):6001-10. doi: 10.1007/s11033-013-2709-x. Epub 2013 Sep 21.

PMID:
24057181
2.

Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.

Leite DB, Junqueira MG, de Carvalho CV, Massad-Costa AM, Gonçalves WJ, Nicolau SM, Lopes LA, Baracat EC, da Silva ID.

Steroids. 2008 Jul;73(6):676-80. doi: 10.1016/j.steroids.2008.02.005. Epub 2008 Feb 23.

PMID:
18384825
3.

Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk.

Yuan C, Liu X, Yan S, Wang C, Kong B.

Biomed Res Int. 2014;2014:648137. doi: 10.1155/2014/648137. Epub 2014 Jun 10.

4.

Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Liu T, Chen L, Sun X, Wang Y, Li S, Yin X, Wang X, Ding C, Li H, Di W.

Tumour Biol. 2014 Mar;35(3):2427-36. doi: 10.1007/s13277-013-1322-x. Epub 2013 Nov 7.

PMID:
24197980
5.

Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.

Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC.

J Natl Cancer Inst. 2005 Jan 5;97(1):51-9.

PMID:
15632380
6.

Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.

Romano A, Lindsey PJ, Fischer DC, Delvoux B, Paulussen AD, Janssen RG, Kieback DG.

Gynecol Oncol. 2006 May;101(2):287-95. Epub 2005 Dec 19.

PMID:
16360811
7.

Association of the progesterone receptor gene polymorphism (PROGINS) with endometriosis: a meta-analysis.

Pabalan N, Salvador A, Jarjanazi H, Christofolini DM, Barbosa CP, Bianco B.

Arch Gynecol Obstet. 2014 Nov;290(5):1015-22. doi: 10.1007/s00404-014-3308-3. Epub 2014 Jun 19.

PMID:
24943061
8.

Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population.

Joshi G, Pradhan S, Mittal B.

Cephalalgia. 2010 Mar;30(3):311-20. doi: 10.1111/j.1468-2982.2009.01967.x. Epub 2010 Feb 11.

PMID:
19673915
9.

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.

Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dubé MP, Kieback DG, Narod SA.

Pharmacogenetics. 2001 Oct;11(7):635-8.

PMID:
11668223
10.

Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?

Lattuada D, Somigliana E, Viganò P, Candiani M, Pardi G, Di Blasio AM.

Clin Endocrinol (Oxf). 2004 Aug;61(2):190-4.

PMID:
15272913
11.

Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.

Shen SQ, Jiang DK, Liu GY, Chen F, Yu L.

Mol Biol Rep. 2012 Apr;39(4):4683-90. doi: 10.1007/s11033-011-1260-x. Epub 2011 Sep 28.

PMID:
21952824
12.

MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.

Liu L, Liao SG, Wang YJ.

Mol Biol Rep. 2012 Nov;39(11):9863-8. Epub 2012 Jul 19.

PMID:
22810649
13.

Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development.

Junqueira MG, da Silva ID, Nogueira-de-Souza NC, Carvalho CV, Leite DB, Gomes MT, Baracat EC, Lopes LA, Nicolau SM, Gonçalves WJ.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):229-32.

PMID:
17291258
14.

Analysis of the Association of Matrix Metalloproteinase-1 Gene Promoter (rs1799750) Polymorphism and Risk of Ovarian Cancer.

Wang L, Kong B.

Int J Gynecol Cancer. 2015 Jul;25(6):961-7. doi: 10.1097/IGC.0000000000000463.

PMID:
25950130
15.

Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients.

Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger R.

Int J Cancer. 2001 Nov 20;95(6):394-7.

16.

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

Pearce CL, Wu AH, Gayther SA, Bale AE; Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group., Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Song H, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore AS, Zheng W, Pharoah PD, Chenevix-Trench G, Pike MC, Schildkraut J, Berchuck A; Ovarian Cancer Association Consortium..

Br J Cancer. 2008 Jan 29;98(2):282-8. doi: 10.1038/sj.bjc.6604170. Epub 2008 Jan 22.

17.

Polymorphisms of progesterone receptor and ovarian cancer risk: a systemic review and meta-analysis.

Liao J, Ding D, Sun C, Weng D, Meng L, Chen G, Ma D.

J Obstet Gynaecol Res. 2015 Feb;41(2):178-87. doi: 10.1111/jog.12519. Epub 2014 Sep 17. Review.

PMID:
25228088
18.

The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.

Ma C, Liu Y, Zhang W, Liu P.

Mol Biol Rep. 2013 Mar;40(3):2061-8. doi: 10.1007/s11033-012-1970-8. Epub 2013 Jan 18.

PMID:
23329275
19.

Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF.

Mol Biol Rep. 2012 Nov;39(11):9921-30. Epub 2012 Jun 26.

PMID:
22733497
20.

The progins progesterone receptor gene polymorphism is not related to endometriosis-associated infertility or to idiopathic infertility.

Gimenes C, Bianco B, Mafra FA, Rosset V, Christofolini DM, Barbosa CP.

Clinics (Sao Paulo). 2010;65(11):1073-6.

Supplemental Content

Support Center